LAUREN MILLER: Open Payments
NPI 1003239245 · YUKON, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,585 in 78 payments from 22 companies in 2025. Trend: 2023 $1,400 · 2024 $1,576 · 2025 $1,585
Food & beverage: $1,585
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 13 | $269 |
| PFIZER INC. | 15 | $265 |
| ABBVIE INC. | 12 | $218 |
| AstraZeneca Pharmaceuticals LP | 5 | $163 |
| SHIELD THERAPEUTICS INC | 3 | $94 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $82 |
| Novo Nordisk Inc | 4 | $64 |
| Otsuka America Pharmaceutical, Inc. | 2 | $56 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Dexcom, Inc. | 2 | $48 |
Products named: MOUNJARO, PREVNAR 20, AIRSUPRA, JARDIANCE, ACCRUFER, UBRELVY, NURTEC ODT, CAPLYTA.
Industry payments across OK — which companies pay providers there.
